| Literature DB >> 16631277 |
Abstract
Drug discovery and delivery to retard the degeneration of joint tissues are challenging. Current treatment is generally inadequate. This commentary places in perspective the inadequacy characteristic of existing therapeutics and the promising developments embodied in the newer therapeutics administered via the oral or intra-auricular routes.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16631277 DOI： 10.1016/j.addr.2006.01.005
Source DB: PubMed Journal: Adv Drug Deliv Rev ISSN： 0169-409X Impact factor: 15.470